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Abstract
Background
The association between diabetes mellitus (DM) and tuberculosis (TB) is re-emerging
worldwide. Recently, the prevalence of DM is increasing in resource poor countries where
TB is of high burden. The objective of the current study was to determine the prevalence
and analyze associated factors of TB and DM comorbidity in South-Eastern Amhara
Region, Ethiopia.
Methods
This was a facility based cross-sectional study. All newly diagnosed TB patients attending
selected health facilities in the study area were consecutively screened for DM. DM was
diagnosed based on theWorld Health Organization diagnostic criteria. A pre-tested semi-
structured questionnaire was used to collect socio-demographic, lifestyles and clinical data.
Logistic regression analysis was performed to identify factors associated with TB and DM
comorbidity.
Result
Among a total of 1314 patients who participated in the study, the prevalence of DM was esti-
mated at 109 (8.3%). Being female [odds ratio (OR) 1.70; 95% confidence interval (CI)
(1.10–2.62)], patients age [41–64 years (OR 3.35; 95% CI (2.01–5.57), 65–89 years (OR
3.18; 95% CI (1.52–6.64)], being a pulmonary TB case [(OR 1.69; 95% CI 1.09–2.63)] and
having a family history of DM [(OR 4.54; 95% CI (2.36–8.73)] were associated factors identi-
fied with TB and DM comorbidity.
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Conclusion
The prevalence of DM among TB patients in South-Eastern Amahra Region is high. Routine
screening of TB patients for DM is recommended in the study area.
Introduction
Historically, the association between tuberculosis (TB) and diabetes mellitus (DM) is well
known and was of great concern for clinicians and investigators at the dawn of the 20th century.
The influence of DM on TB was, however, neglected after the discovery of potent treatment
regimens for both diseases [1–4]. Currently, the association between DM and TB is re-emerg-
ing worldwide. Cases of DM are increasing in resource poor countries where TB is of a high
burden [1–2]. In 2013, there were an estimated 9.0 million incident cases, and 1.5 million TB
deaths globally [5]. In the same year, DM affected 382 million people and killed 5.1 million per-
sons. It is projected that the number of people affected by DM will increase to 592 million by
2035 [6] and about 80% of these people live in low and middle income countries where TB is
endemic [5–6].
DM triples the risk of developing active TB among infected individuals [7]. It also increases
susceptibility toMycobacterium tuberculosis infection and development of diseases. DM
directly impairs innate and adaptive immune responses that are necessary to counter the pro-
gression from infection to clinical diseases [8]. The association between DM and TB is sup-
ported by the fact that patients with DM have impaired cell-mediated immunity, renal failure,
micronutrient deficiency and pulmonary microangiopathy, all of which increase their suscepti-
bility to develop TB disease [4, 8–9]. Studies conducted in different parts of the world have
shown that 12%-44% of TB diseases were associated with DM [10–15].
Ethiopia is one of 22 high TB burden countries in the world [16] with an estimated inci-
dence and prevalence rates of 210/100000 and 200 /100000 population, respectively [5]. Cur-
rently, the country is also facing an increasing rate of DM among its population. With a 4.36%
prevalence among its population, Ethiopia is the 3rd highest country in Africa in terms of DM
burden [6].
Few studies conducted in Ethiopia reported the magnitude of TB and DM comorbidity [17–
19]. However, as these studies were limited to few government hospitals located in major
urban areas of some parts of the country, it did not show the burden of the two comorbid con-
ditions among patients from rural areas. It also did not include patients attending private and
peripheral health facilities (HFs) where the directly observed treatment short course (DOTS)
and DM service are provided. The objective of the current study was to determine the preva-
lence and associated factors of DM among TB patients attending selected HFs in South-Eastern
Amhara Region, Ethiopia.
Methods
Study setting
The study was conducted in South-Eastern part of Amhara Region, Ethiopia. South-Eastern
part of Amhara Region consists of four zones and one City Administration namely: North
Wollo, South Wollo, North Shewa, Oromia Special Zone and Dessie City Administration (Fig
1).The total population of these zones and City Administration is estimated at 7,358,301. Of
these, were 3,684,735 men and 3,673,566 women [20].
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Study design, population and sample size
This was a facility based cross-sectional study which was conducted between September 2013
till September 2014.The study population included all newly diagnosed TB patients aged15
years who were attending DOTS clinics at selected HFs in the study area. Newly diagnosed TB
patients aged 15 years and above, transferred in newly diagnosed TB patients who had never
started TB treatment in the transferring out HFs and known DM patients who were newly
diagnosed for TB were included in the study. Patients less than 15 years of age, "re-treatment"
cases, known or suspected multi- drug resistance (MDR) TB cases, patients who were disabled
and could not respond to the interview were excluded from the study. The sample size was cal-
culated using the standard formula for estimating a single population proportion, (n) = {[z2p
(1-p)]/d2}. Therefore, by considering 50% proportion, 95% confidence interval (C.I.) and a
margin error of 3%, the sample size was calculated to be 1067. By adding 10% for no response,
the total sample size required was 1174 TB patients.
TB diagnosis was made based on guideline developed for the national clinical and program-
matic management of TB in Ethiopia. Smear- positive pulmonary TB (PTB) was diagnosed in
a patient with at least two sputum smear examinations positive for acid-fast bacilli (AFB) or in
a patient with one initial smear examination positive for AFB and radiographic abnormalities
consistent with active TB as determined by a clinician. Smear-negative PTB was diagnosed in a
patient having symptoms suggestive of TB with at least 3 initial smear examinations negative
Fig 1. Map of study area (Source: Ethiopia (https://commons.wikimedia.org/wiki/File:Ethiopia-Amhara.png), Amhara Region (https://www.
ethiodemographyandhealth.org/Amhara.html)). Accessed on December 29 / 2015.
doi:10.1371/journal.pone.0147621.g001
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for AFB by direct microscopy and no response to a course of broad-spectrum antibiotics, and
again three negative smear examinations by direct microscopy, and radiological abnormalities
consistent with PTB, and decision by a clinician to treat with a full course of anti-TB chemo-
therapy.The diagnosis of extra PTB (EPTB) was made by identifying AFBs in organs other
than lung proven by at least one specimen with confirmedMycobacterium tuberculosis or his-
tological or strong clinical evidence consistent with active EPTB, followed by a decision by a
clinician to treat with a full course of anti-TB chemotherapy [16].
All consenting patients were subjected to screening for DM before the start of anti-TB treat-
ment. Screening for DM was done either by random blood sugar (RBS) test right after the
arrival of the patient at DOTS unit, and/or fasting blood sugar (FBS) in the morning of the fol-
lowing day after the patient came in fasting state. DM diagnosis was made when RBS test was
found to be 200 mg/dl with the presence of classical sign and symptom of DM and /or FBS
test result126 mg/dl at two different times in accordance with the World Health Organiza-
tion (WHO) DM diagnostic criteria [21]. Self-reporting of having DM was also considered for
the diagnosis of DM. Finally, participants were categorized into two groups i.e. TB patient’s
comorbid with DM (TBDM) and TB patients not comorbid with DM (TBNDM) based on
their DM status. Provider initiated counseling and testing (PICT) service was provided to
screen patients for human immuno-deficiency virus (HIV).
Sampling methods
Random sampling technique was applied to select study sites. There were a total of 420 HFs
(326 (78%) government and 94 (22%) private HFs) in the study area. Of these, only 102 (31%)
government and 20 (21%) private HFs were eligible to provide TB, HIV and DM diagnostic
and treatment services. Among the 20 private HFs, only 5 (25%) provided TB, HIV and DM
services in a continuous manner. Fifteen (75%) of the private HFs encountered frequent TB
service interruption for various reasons and were excluded. Finally, out of the 102 (31%) gov-
ernment HFs eligible for the study, we randomly selected 39 (38%) HFs. We also added all of
the five private HFs that continuously provide TB, HIV and DM services which makes a total
of 44 (41%) study sites (Fig 2).
Data collection and quality assurance
Health workers who provide anti-TB treatment at DOTS unit, laboratory technologist, and a
clinician responsible for diagnosis as well as follow up of TB and DM were trained and assigned
as data collectors at each study site. Training and pretesting of the questionnaire were con-
ducted at Dessie Health Center (HC). The pre-test result was first discussed and necessary cor-
rections were made on the questionnaire before the actual data collection commenced. The
data included soicio-demographic, lifestyle, and clinical parameters including HIV sero-status
and body mass index (BMI). To ensure the quality of data, questionnaires were thoroughly
checked for completeness and consistency by study supervisors and principal investigator.
Manufacturer’s code strips for glucometer and control standard for calibration of auto-analyzer
was used to maintain the quality of blood glucose measurement. Internal and external quality
control was also ensured for AFB smear microscopy test.
Ethical approval
The study was initiated after ethical approval was obtained from the Regional Committee for
Research Ethics in Norway (REC-Øst, Norway) and Ethiopian Science and Technology Minis-
try. Permission from Amhara Regional State Health Bureau and from health authorities of the
study sites was also received prior to the start of the study. Oral and written information was
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provided to study participants before informed consent was obtained. Parents/guardians gave
consent for study subjects who were between 15 years to 17 years of age. Those TB patients
who were found to have DM and HIV were referred to DM and anti-retroviral therapy (ART)
clinics for further investigation and appropriate management.
Statistical analysis
Data entry, cleaning and analysis were performed using Statistical Package for Social Science
(SPSS) version 22 Armonk, New York 10504 IBM Corp. Patients with non-conclusive blood
glucose test results for DM diagnosis were excluded from the analysis. The main outcome vari-
ables were proportions of patients with a diagnosis of TBDM and TBNDM. Categorical vari-
ables were expressed as proportions and chi-square analysis was performed to compare
proportions. Student’s t test was used to compare means for normally distributed variables.
Multivariate logistic regression analysis was performed to analyze the association of predictor
variables with the outcome variable. Variables that have a p-value of 0.2 in the univariate
analysis were included in the final model of multivariate analysis. A p-value 0.05 was consid-
ered statistically significant. Acceptance of screening was measured by proportion of
Fig 2. Schematic representation of sampling techniques for selection of study site health facilities (HFs). TB-tuberculosis, HIV-human immuno-
deficiency virus, DM-diabetes mellitus.
doi:10.1371/journal.pone.0147621.g002
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participants who consented, and underwent DM screening among those eligible patients
invited by the data collectors. The effectiveness of the screening approach was measured using
the number of TB patients needed to screen (NNS) to get one additional new DM case and was
calculated by the reciprocal proportion of newly detected DM cases.
Results
Socio-demographic characteristics of study subjects
Of the total 1353 newly diagnosed TB patients who fulfilled the inclusion criteria, 1335 (98.7%)
patients consented and underwent screening. Eighteen (1.3%) patients refused to participate in
the screening. Reasons for refusal included lack of money for screening test 15 (1.1%) and fear
of losing their blood 3 (0.2%). Among 1335 (98.7%) patients enrolled in the study, 21 (1.6%)
did not have confirmatory result for DM and were excluded from the analysis. A total of 1314
participants were included in the final analysis and of these were 692 (52.7%) males and 622
(47.3%) females. The study participant’s age ranged from 15 years to 89 years and the mean
age including standard deviation (SD) was 35.74 (±15.26) years. Majority, 928 (70.6%) of the
study subjects were in the age range of 15 years to 40 years, were urban residents, had no formal
schooling, and had a monthly income of 18.9 United States Dollar (USD).
Prevalence of DM among study subjects
The overall prevalence of DM in this study was 109 (8.3%). Of which 45 (3.4%) were known
DM patients and 64 (4.9%) were newly diagnosed DM cases. The median duration of DM
among known DM patients before TB diagnosis was two years and the highest was four years.
The prevalence of DM was higher among patients in the younger age group, urban residents
and married individuals (Table 1).
The NNS to find one new cases of DM was 19.8.The NNS was lower among females,
patients in the older age group and rural dwellers (Table 2). Of the total 109 (8.3%) DM cases,
93 (85.3%) were identified at HCs, 8 (7.3%) at government hospitals and 8 (7.3%) at private
hospitals.
Clinical characteristics
Seven hundred seventy (58.6%) of the study participants were PTB patients, and of these, 420
(54.5%) were smear negative cases. Majority, 70 (64.2%) of TBDM patients were PTB cases.
One hundred thirty nine (11.5%) of study participants had impaired fasting glucose (IFG).
Mean (±SD) FBS and RBS values were higher among the TBDM group compared to patients
in the TBNDM group. Both TBDM and TBNDM groups were equally affected by HIV. Of the
22 (20.2%) HIV infected TBDM comorbid patients, majority, 15 (68.2%) were newly diagnosed
DM cases. One hundred forty three (59.8%) TBNDM and 12 (54.5%) TBDM patients were on
ART during the study period (Table 3).
Lifestyle factors
Majority of the participants were found to have never smoked cigarette, were non-alcohol
drinkers, did not chew Khat (mild narcotic herb) and had no known contact with a TB patient.
Seventeen (15.6%) patients in the TBDM group had a family history of DM compared to 51
(4.2%) of the patients in the TBNDM group. Most of the study participants, 788 (60.0%) had a
BMI of<18.5 kg/m2. Majority, 6 (5.5%) TBDM patients had a BMI of 25kg/m2 compared to
31 (2.6%) TBNDM patients (Table 4).
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Factors associated with TBDM comorbidity
Multivariate logistic regression analysis revealed that patients in the TBDM group were more
likely to be females [(OR = 1.70; 95% CI 1.10–2.62), 41–64 years of age (OR = 3.35; 95% CI
2.01–5.57), 65–89 years of age (OR = 3.18; 95% CI 1.52–6.64), PTB case (OR = 1.69; 95% CI
1.09–2.63) and having a family history of DM (OR = 4.54; 95% CI 2.36–8.73)] (Table 5).
Table 1. Socio-demographic back ground of the study participants, South-Eastern Amhara Region,
Ethiopia, September 2013—September 2014.
Variables Type of patients
All TB N (%) TBNDM N (%) TBDM N (%)
Total 1314 1205 109
Sex
Male 692 (52.7) 642 (53.3) 50 (45.9)
Female 622 (47.3) 563 (46.7) 59 (54.1)
Age in years
15–40 928 (70.6) 877 (72.8) 51 (46.8)*
41–64 285 (21.7) 240 (19.9) 45 (41.3)
65–89 101 (7.7) 88 (7.3) 13 (11.9)
Mean (± SD) 35.74 (± 15.26) 35.02 (± 15.06) 43.73 (± 15.33)*
Residence
Urban 826 (62.9) 767 (63.7) 59 (54.1)*
Rural 488 (37.1) 438 (36.3) 50 (45.9)
Religion
Christian 548 (41.7) 508 (42.2) 40 (36.7)
Muslim 766 (58.3) 697 (57.8) 69 (63.3)
Marital status
Single 395 (30.1) 373 (31.0) 22 (20.2)
Married 919 (69.9) 832 (69.0) 87 (79.8)*
Education
No formal schooling 618 (47.0) 558 (46.3) 60 (55.0)
1–6 grade 252 (19.2) 235 (19.5) 17 (15.6)
7–12+1 362 (27.5) 339 (28.1) 23 (21.1)
Diploma and above 82 (6.2) 73 (6.1) 9 (8.3)
Occupation
Unemployed 376 (28.6) 340 (28.2) 36 (33.0)
Student 112 (8.5) 106 (8.8) 6 (5.5)
Self-employed 725 (55.2) 672 (55.8) 53 (48.6)
Government employed 101 (7.7) 87 (7.2) 14 (12.8)
Monthly income (USD)¶
No income 167 (12.7) 156 (12.9) 11 (10.1)
 18.9 506 (38.5) 465 (38.9) 41 (37.6)
19–37.9 303 (23.1) 277 (23.0) 26 (23.9)
 38 338 (25.7) 307 (25.5) 31 (28.4)
¶ 1USD = 21.1 Ethiopian birr
*P-value 0.05
TB- tuberculosis, TBNDM- tuberculosis patient not comorbid with diabetes mellitus, TBDM- tuberculosis
patient comorbid with diabetes, SD- standared deviation, USD-United States Dollar
doi:10.1371/journal.pone.0147621.t001
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Discussion
In this study, we found 8.3% DM prevalence among newly diagnosed TB patients which is
higher than the DM prevalence reported in the general population in Ethiopia [6].The finding
is in agreement with a previous study reported from the study area [17–18].It is also compara-
ble with the study done in Jammu-India (8.2%) and Uganda (8.5%) [22–23] but lower than
that reported from Taiwan (29.5%), Southern-Mexico (29.3%) and Kerela–India (44%) [13–
15]. Reasons for the observed variation in prevalence might be related to differences in back-
ground between population and screening methods used in DM diagnosis [23–24].
The prevalence of pre-diabetes in our study was 11.5%.This finding is higher than the study
done in China (7.8%) [25], Gujarat-India (7%) [26], Saluru–India (8.5%) [27] and Kolar–India
(3.1%) [28] but lower than the study finding from Gondar (29.6%), Addis Ababa-Ethiopia
Table 2. Number of TB patients needed to screen to find a new case of DM, South- Eastern Amhara Region, Ethiopia, September 2013-September
2014.
Characteristics Number of TB patient screened for
DM
Known DM
patients
Patient newly diagnosed for
DM
Numbers needed to
screen
Total 1314 45 64 19.8
Sex
Male 692 19 31 21.7
Female 622 26 33 18.1
Age in years
15–40 928 17 34 26.7
41–89 386 28 30 11.9
Residence
Urban 826 25 34 23.5
Rural 488 20 30 15.6
Marital status
Single 395 10 12 32
Married 919 35 52 17
Education
No formal schooling 618 23 37 16.1
1–6 grade 252 9 8 30.3
7–12+1 362 7 16 22.2
Diploma and above 82 6 3 25.3
Type of TB
PTB 770 29 41 18
EPTB 544 16 23 22.9
Khat chewer
Chewer 433 19 24 17
Non-chewer 881 26 40 21.3
HIV status
Positive 261 7 15 16.9
Negative 1045 38 49 20.5
Family history of
DM
Yes 68 10 7 8.2
No 1246 35 57 21.2
TB- tuberculosis, DM- diabetes mellitus, PTB- pulmonary tuberculosis, EPTB- extra pulmonary tuberculosis, HIV- human immuno-deﬁciency virus
doi:10.1371/journal.pone.0147621.t002
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(26.7%) and Tamil Nadu–India (24.5%) [18–19, 29].This finding may indicate an increased
risk of DM in the future in Ethiopia. Lifestyle change and health promotion activity may delay
the onset of DM [25, 27]. The observed DM and prediabetes prevalence in the studied group
threatens the gains made in TB control and warrants integrated health services approach to
address the burden of the two diseases.
The proportion of new DM cases 64 (4.9%) identified in our study is similar to the study
done in India (5%) [30], but higher than from China (3%), Gujarat-India (4%), Saluru–India
(3.2%), Kolar–India (2.9%) and Mexico (4.4%) [25–28, 31] and lower than the study finding in
Trivandrum-India (7%) [32]. The relatively high proportion of undiagnosed DM in the study
may indicate the magnitude of the disease, low awareness, lack of access to DM services, the
importance of DM screening among TB patients which is crucial for early diagnosis and treat-
ment of the two comorbid conditions [18–19, 27,31,33].
The number of patients that underwent screening for DM in our study is high and is consis-
tent with the studies done in China [25], Gujarat-India [26] and Saluru–India [27]. HIV
counseling and testing service is provided to all TB patients in the study area and this may have
helped as an entry point for increased number of DM screening among patients The finding
suggests that the screening strategy of TB patients for DM is acceptable and feasible [27].
Table 3. Clinical characteristics of study participants, South-Eastern Amhara Region, Ethiopia, September 2013—September 2014.
Characteristics Type of patients
All TB TBNDM TBDM
Type of TB (n = 1314)
PTB 770 (57.6) 700 (58.1) 70 (64.2)
EPTB 544 (41.4) 505 (41.9) 39 (35.8)
Sputum status (n = 770)
Positive 350 (45.5) 322 (46.0) 28 (40.0)
Negative 420 (54.5) 378 (54.0) 42 (60.0)
FBS (mg/dl) (n = 1207)
< 110 972 (80.5) 971 (87.6) 1 (1.0)
110–125 139 (11.5) 137 (12.4) 2 (2.0)
126–650 96 (8.0) 0 (0.0) 96 (97.0)
Mean (± SD) 102.68 (± 37.88) 95.27 (± 12.17) 185.72 (± 91.66)*
RBS (mg/dl) (n = 107)
< 200 99 (92.5) 97 (100.0) 2 (20.0)
 200 8 (7.5) 0 (0.0) 8 (80.0)
Mean (± SD) 125.07 (± 79.98) 104.98 (± 21.38) 320.00 (± 154.58)*
HIV status (n = 1306)
Negative 1045 (80.0) 958 (80.0) 87 (79.8)
Positive 261 (20.0) 239 (20.0) 22 (20.2)
HIV therapy (n = 261)
Pre-ART 106 (40.6) 96 (40.2) 10 (45.5)
ART 155 (59.4) 143 (59.8) 12 (54.5)
*P value 0.05
TB- tuberculosis, TBNDM- tuberculosis patient not comorbid with diabetes mellitus, TBDM- tuberculosis patient comorbid with diabetes, PTB-pulmonary
tuberculosis, EPTB-extra pulmonary tuberculosis, FBS-fasting blood sugar, RBS-random blood sugar, mg-milligram, dl-decilitre, SD-standared deviation,
HIV- human immuno-deﬁciency virus
doi:10.1371/journal.pone.0147621.t003
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The NNS to detect a new case of DM among TB patients was 19.8. This number is lower
than the finding documented in Gujarat-India, Saluru -India and Kolar–India [26–28] but five-
fold higher than the results reported from Kerela-India [15]. The reason for this variation may
be due to the high prevalence of DM, the quality of screening test used and the countrywide
standard procedure applied for DM screening in India [30]. Given our study findings, it may
be more effective to screen specific group of patients including females, patients 41 and above
years of age, rural dwellers, married persons, patients who do not have formal education, PTB
cases, khat chewers, HIV positive individuals and patients with a family history of DM.
The numbers of DM cases identified among patients attending HCs were higher compared
to patients that went to government hospitals and private HFs. This finding is in line with stud-
ies done in Saluru–India, Kolar-India, Mexico and Trivandrum-India [27–28, 31–32] but in
contrast to the study conducted in India where majority of DM patients were diagnosed at hos-
pitals [30]. The high number of DM patients presenting at periphery level HFs might be related
to increased geographical coverage of TB services in the study area. In addition, TB patients
who are diagnosis at hospital are usually transferred out to the nearby HFs where they can eas-
ily access anti-TB treatments. This finding may indicate the possibility of DM screening at
periphery HFs, and the need to access and strengthen DM services where TB services are
rendered.
Table 4. Lifestyle factor among study participants, South-Eastern Amhara Region, September 2013-September 2014.
Characteristics Type of patients
All TB N (%) TBNDM N (%) TBDM N (%)
Total 1314 1205 109
Cigarette
Never smoke 1195 (90.9) 1093 (90.7) 102 (93.6)
Smoker 119 (9.1) 112 (9.3) 7 (6.4)
Alcohol
Non-drinker 947 (72.1) 867 (72.0) 80 (73.4)
Drunker 367 (27.9) 338 (28.0) 29 (26.6)
Khat
Non-chewer 881 (67.0) 815 (67.6) 66 (60.6)
Chewer 433 (33.0) 390 (32.4) 43 (39.4)
Contact with TB patients
No 1121 (85.3) 1022 (84.8) 99 (90.8)
Yes 193 (14.7) 183 (15.2) 10 (9.2)
Family history of DM
Absent 1246 (94.8) 1154 (95.8) 92 (84.4)
Present 68 (5.2) 51 (4.2) 17 (15.6)*
BMI(kg/m2)
< 18.5 788 (60.0) 729 (60.5) 59 (54.1)
18.5–24.9 489 (37.2) 445 (36.9) 44 (40.4)
 25 37 (2.8) 31 (2.6) 6 (5.5)
Mean (± SD) 18.07 (± 3.01) 18.05 (± 2.94) 18.35 (± 3.72)
* P value  0.05
TB- tuberculosis, TBNDM- tuberculosis patient not comorbid with diabetes mellitus, TBDM- tuberculosis patient comorbid with diabetes, DM- diabetes
mellitus, BMI- body mass index, kg- kilogram, m2- meter square, SD- standard deviation
doi:10.1371/journal.pone.0147621.t004
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In this study, being female was identified as a risk factor for TBDM comorbidity. This find-
ing is similar with previous studies done in Saskatchewa [34] and Texas-Mexico [35]. But it is
in contrast to the study done in Kerela-India [15]. The reasons may be linked to poor health
service utilization, caretaking role of women for the sick and influence of estrogen on cytokine
production during TB infection. These conditions may increase vulnerability of women to TB
and consequently to DM [34].
Study participants in the TBDM group were significantly older than the TBNDM group.
This finding is in line with the studies done in Southern-Mexico, Dessie-Ethiopia and Brazil
Table 5. Factors associated with TBDM comorbidity, South-Eastern Amahra Region, Ethiopia, Sep-
tember 2013 -September 2014.
Variables Crude OR (95% CI) Adjusted OR (95% CI)¶
Sex
Male 1 1
Female 1.35 (0.91–1.99) 1.70 (1.10–2.62)*
Age in years
15–40 1 1
41–64 3.22 (2.11–4.93)* 3.35 (2.01–5.57)*
65–89 2.54 (1.33–4.85)* 3.18 (1.52–6.64)*
Residence
Urban 0.67 (0.45–1.00) 0.65 (0.41–1.03)
Rural 1 1
Education
No formal schooling 1 1
1-6grade 0.67 (0.38–1.18) 0.92 (0.49–1.69)
7–12+1 0.63 (0.38–1.04) 1.05 (0.56–1.97)
Diploma and above 1.15 (0.55–2.41) 2.34 (0.96–5.74)
Marital status
Single 1 1
Married 1.77 (1.09–2.86) 0.97 (0.55–1.74)
Type of TB
EPTB 1 1
PTB 1.29 (0.86–1.95) 1.69 (1.09–2.63)*
Khat
Non-chewer 1 1
Chewer 1.36 (0.91–2.04) 1.49 (0.97–2.29)
Family history of DM
Yes 4.18 (2.32–7.53)* 4.54 (2.36–8.73)*
No 1 1
BMI (kg/m2)
< 18.5 1 1
18.5–24.9 1.22 (0.81–1.84) 1.47 (0.95–2.27)
 25 2.39 (0.96–5.96) 2.57 (0.91–7.25)
* P value 0.05
¶ - adjusted for sex, age, residence, education, marital status, type of TB, khat chewing, family history of
DM and BMI.
TB- tuberculosis, CI-conﬁdence interval, EPTB- extra pulmonary tuberculosis, PTB- pulmonary
tuberculosis, DM- diabetes mellitus, BMI- body mass index, kg- kilogram, m2-meter square, OR-odds ratio
doi:10.1371/journal.pone.0147621.t005
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[14, 17, 36]. Increasing age was also identified as one of the risk factors for TBDM comorbidity
which is consistent with studies done in Kerela-India [15], Addis Ababa–Ethiopia [19], Tamil
Nadu–India [29], Trivandrum–Kerela India [32], China [37] and Puducherry- India [38].
Increasing age is linked to immunosuppression and is one of the risk factor for both TB and
DM [2, 6, 17].
Similar to studies done in Malappuram-India [39], Tamil Nadu–India and Trivandrum–
Kerela India [29, 32], the prevalence of PTB among patients in the TBDM group was higher
than TBNDM group. This might be related to defects in immune functions and decrease capac-
ity of alveolar macrophage to eliminate mycobacterial infection in DM patients [3–4, 9, 40].
The lung is the predominant site of TB diseases among immunocompetent patients [41].
The overall prevalence of HIV (20.0%) is higher than the DM prevalence (8.3%) observed in
the study. The finding is in accordance with the study done in Gondar-Ethiopia [18] but in
contrast to the study result reported fromMalappuram-India [39]. This might be due to the
high prevalence of HIV in the study area. Surprisingly, the HIV sero-positivity among both
TBDM and TBNDM patient groups was high and is more or less similar with the study done
in Addis Ababa-Ethiopia [19].The high number of TB, HIV and DM comorbidity reflects the
association of all three diseases and suggests the need for implementing the three-pronged (TB,
HIV and DM) collaborative control strategy within the existing health care delivery system.
The observed high number of newly detected DM cases among TBHIV comorbid patients may
be linked to changes in quality of life and adverse effect of using ART drugs among HIV-posi-
tive patients [42]. The high number of DM among HIV positive patients may contribute to
increased TB incidence and complication of illness among patients [19]. Routine screening of
HIV patients for DM in addition to TB may enhance early detection and better management of
DM among TB/HIV coinfected individuals.
The prevalence of TBDM was higher among patients who have a family history of DM. This
finding is in line with studies done in Addis Ababa–Ethiopia [19]. Having a family history of
DM was among the factors identified that influences the occurrence of TBDM comorbidity.
This finding is in line with the study done in Tamilu Nadu-India, China and Puducherry
-India [29, 37–38]. Having a family history of DM is known risk factor for DM [6].
The major strength of this study is that it covered urban and rural areas and included gov-
ernment and private HFs at different levels where both DOTS and DM services are simulta-
neously rendered. Also the enrollment of large number of participants in a consecutive manner
reduces selection bias. The following limitations also need worthy of mentioning. We used RBS
and FBS tests for making the diagnosis of DM. As these tests have lower sensitivity and speci-
ficity compared to oral glucose tolerance test (OGTT) and glycated haemoglobin (HbA1c) [21,
43], we may have underestimated the prevalence of DM among TB patients. In addition, signif-
icant number of TB patients whose first DM test result was not conclusive to determine the
DM status were excluded from the analysis. This may also contribute to underestimation of the
true DM prevalence. TBDM patients who did not visit medical providers for their symptoms
may also contribute to underestimation of the magnitude of TBDM comorbid conditions in
the study area. We cannot also assess the factors associated for the acceptability of screening
because of lack of comparative groups. Social desirability bias due to denial of telling smoking,
alcohol drinking and khat chewing habits may affect the study findings related to behavioral
risk factors for DM and TB comorbidity.
Conclusion
The prevalence of DM among TB patients observed in our study is high and may indicate an
emerging threat of TBDM comorbidity in Ethiopia in general and South-Eastern Amhara
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Region in particular. Being female, 41 and above years of age, PTB case and having a family his-
tory of DM are important risk factors for TBDM comorbidity. Health education about the
importance of getting tested for DM should be given to all TB patients in the study area. Given
the rapidly changing economic development in Ethiopia, it may be an appropriate time to
think about considering the need for integrated TB and DM service to reduce the burden of the
two diseases in the country. In this regard, our study finding may serve as a baseline for larger
studies and as a background evidence for policy debate for future possibilities of integrating
DM screening into the existing health system in Ethiopia.
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